For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Xenoport, Inc.

USPTO Granted Patents = 142

% Expired Patents = 70.4

CIPO Patents = 6

EPO Patents = 16

Trademarks = 1

Forward Citations = 1,058

Loading Chart...

Loading Chart...

68 inventors (with patents filed for the assignee):

Mark A Gallop (84 out of 107 patents)

Kenneth C Cundy (36 out of 38 patents)

Cindy X Zhou (33 out of 34 patents)

4. Jia-Ning Xiang (32 out of 77 patents)

5. Fenmei Yao (31 out of 33 patents)

6. Noa Zerangue (25 out of 25 patents)

7. Xuedong Dai (21 out of 21 patents)

8. Stephen P Raillard (19 out of 19 patents)

9. Suresh Kumar Manthati (17 out of 24 patents)

10. Ge Peng (16 out of 24 patents)

11. Mark Quang Nguyen (16 out of 34 patents)

12. Randall A Scheuerman (16 out of 20 patents)

13. William J Dower (13 out of 77 patents)

14. Ronald W Barrett (13 out of 65 patents)

15. Thu Phan (12 out of 15 patents)

Core Competencies:

Prodrugs

GABA Analogs

Levodopa

Fumarate Esters

Oral Dosage Forms

Pharmaceutical Compositions

Acyloxyalkyl Carbamate

Sustained Release

Creatine Phosphate

Cocrystals

Synthesis Methods

Bioavailability

142 patents: Sort by Forward Citations

1. 10071068 - Sustained release oral dosage forms of an R-baclofen prodrug (2018-09-11),

2. 9999672 - Pharmaceutical compositions of fumaric acid esters (2018-06-19),

3. 9949941 - GABA analog prodrug sustained release oral dosage forms (2018-04-24),

4. 9944592 - Acyloxyalkyl carbamate prodrugs, methods of synthesis and use (2018-04-17),

5. 9895336 - Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use (2018-02-20),

6. 9795581 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use (2017-10-24),

7. 9682057 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use (2017-06-20),

8. 9597292 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2017-03-21),

9. 9533941 - Methods of synthesizing a levodopa ester prodrug (2017-01-03),

10. 9452972 - Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof (2016-09-27),

11. 9421182 - Cocrystals of dimethyl fumarate (2016-08-23),

12. 9416096 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use (2016-08-16),

13. 9353057 - Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof (2016-05-31),

14. 9302977 - Method of making monomethyl fumarate (2016-04-05),

15. 9290445 - Methods of synthesizing a levodopa ester prodrug (2016-03-22),

XenoPort, Inc. is a biopharmaceutical company dedicated to the development of innovative medicines for neurological and other disorders. With a focus on addressing unmet medical needs, XenoPort aims to improve the lives of patients through the discovery, development, and commercialization of novel therapeutics. Through rigorous research and strategic collaborations, XenoPort is committed to advancing the future of medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

142 Patents

#32 in Santa Clara, CA

#608 in California

#2,747 in US

#5,709 in the World

Santa Clara, CA, United States of America

Xenoport, Inc.

Forward Citations = 1,058

68 inventors:

Mark A Gallop (84 out of 107 patents)

Kenneth C Cundy (36 out of 38 patents)

Cindy X Zhou (33 out of 34 patents)

4. Jia-Ning Xiang (32 out of 77 patents)

5. Fenmei Yao (31 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…